Journey Medical's future hinges on Emrosi, a new formulation of minocycline for rosacea, showing superior efficacy. Read why ...

The main focus in Teva’s innovative portfolio continues to be neuroscience and immunology, with clinical trials for three key ...

With no regionally commissioned services for adult ADHD in Northern Ireland. health trusts have no requirement to manage ...

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

A new study shows a possible new abortion drug to replace mifepristone. But will these results increase abortion access—or restrict women's reproductive health options down the line?

Four of our panelists discuss their favorite investments in the final installment of our 2025 stock-picking confab.

If you've ever been frustrated while shopping at your local pharmacy, you're hardly alone — but now CVS has devised a plan to ...

It's also worth pointing out that CVS Health seems to have plenty of space to increase its dividend. The company's cash ...

CVS Health (NYSE: CVS) is a big name in healthcare, and it has generally been seen as a good way to invest in the industry. In addition to its pharmacy retail operations, the company has a ...

CVS Health surpassed consensus EPS estimates three times. The company topped consensus revenue estimates two times over this period. Without considering a stock's valuation, no investment decision ...

CVS' diverse operations create the opportunity to view a patient more holistically by managing both medical and pharmacy benefits, which could lead to revenue and cost synergies for the organization.